Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SeaSTAR: Emixustat for Stargardt Disease
NCT03772665Phase 3Completed
- Sponsor
- Kubota Vision
- Start
- Jan 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of emixustat in Stargardt disease (STGD), sponsored by Kubota Vision. Started Jan 2019; status: completed.
02
Drugs
emixustat
03
Conditions
Stargardt disease (STGD)
Beyond the preview
Go deeper on NCT03772665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772665.